Budget Submissions: PSA, ASMI and Research Australia

This is a preview of subscriber content

Subscribe now to continue reading.

PSA calls for an incentive payment to better integrate pharmacy into general practice, ASMI for the creation of a regulatory environment that promotes 'self care', while Research Australia recommends some alternative savings measures to ensure funding to the Medical Research Future Fund. …

Subscribe now to continue reading.

Budget Submissions: PSA, ASMI and Research Australia

This is a preview of subscriber content

Latest Video

Most Read

Australia risks a two tier health system as patients take their fight to Canberra

'You can't fix a broken system by tinkering with parts of it'

Guilt over this enduring failure is the correct response

Artificial intelligence in HTA has arrived, kind of, but nobody was thinking of this

The forgotten patients living in the long shadow of rare cancer

New Stories

NSW pharmacists to deliver all childhood vaccines and treat more conditions under reforms

Rare genetic motor neurone disease treatment finally reaches Australian patients

Taking a stake is not the same as spectating investor risk and expecting a benefit

Artificial intelligence in HTA has arrived, kind of, but nobody was thinking of this

Melbourne oncologist takes the reins at Australia's private cancer physicians body

Australia secures sovereign viral vector manufacturing as VVMF wins TGA licence

Which is it? The two perspectives on patient input compounded by the lack of transparency

Sign In

Budget Submissions: PSA, ASMI and Research Australia

This is a preview of subscriber content

Latest Video

Most Read

Australia risks a two tier health system as patients take their fight to Canberra

'You can't fix a broken system by tinkering with parts of it'

Guilt over this enduring failure is the correct response

Artificial intelligence in HTA has arrived, kind of, but nobody was thinking of this

The forgotten patients living in the long shadow of rare cancer

Follow Us

New Stories

NSW pharmacists to deliver all childhood vaccines and treat more conditions under reforms

Rare genetic motor neurone disease treatment finally reaches Australian patients

Taking a stake is not the same as spectating investor risk and expecting a benefit

Artificial intelligence in HTA has arrived, kind of, but nobody was thinking of this

Melbourne oncologist takes the reins at Australia's private cancer physicians body

Australia secures sovereign viral vector manufacturing as VVMF wins TGA licence

Which is it? The two perspectives on patient input compounded by the lack of transparency